Keyword: Sanofi

Strategy & Management

Increased Process Performance and Safety

08.04.2019 - It took about two decades after micro and milli reactor technology has reached the production scale with significant production volumes. Now, curiosity and openness of chem­ical...

Strategy & Management

A Technology Whose Use is Indispensable

08.04.2019 - The existing market situation has already led to a shift in strategy from large quantity chemicals to highly innovative specialties. For many syntheses you can use classical batch...

Strategy & Management

Flow Chemistry: Key Technology for Sustainable Processes

08.04.2019 - You can call it flow chemistry or micro reaction technology (MRT) — both terms describe a technology with enormous advantages for many process engineering applications. It replaces...

News

Sanofi’s Oral Sleeping Sickness Drug Approved

01.02.2019 - French drugmaker Sanofi’s fexinidazole-basesd all-oral treatment for sleeping sickness (Trypanosoma brucei gambiense human African trypanosomiasis, HAT) has received marketing...

News

Sanofi Pays to Exit Regeneron Pact

10.01.2019 - France’s Sanofi is paying $462 million to exit the immuno-oncology pact it established with US biotech Regeneron in 2015 half a year earlier than planned. With the severance...

News

Sanofi Invests €80 Million in BioNTech

08.01.2019 - French multinational pharmaceutical company Sanofi is investing €80 million in Germany’s BioNTech. At the same time, the two companies have agreed to extend their research...

News

Sanofi to Slash Jobs In France

11.12.2018 - Sanofi is seeking to cull its workforce as it resets priorities. A French union representative told the news agency Reuters that the drugmaker is targeting 670 “voluntary...

News

Sanofi and Denali Target MS and ALS

15.11.2018 - French drugmaker Sanofi and Denali Therapeutics of the US plan to cooperate on developing molecules discovered by Denali that have the potential to treat multiple sclerosis (MS)...